Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16% - PRNewswire
Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16% PRNewswire
NASHVILLE, Tenn., Feb. 26, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on ...
Comments
Post a Comment